Format

Send to

Choose Destination
Front Microbiol. 2011 Sep 27;2:198. doi: 10.3389/fmicb.2011.00198. eCollection 2011.

Development of vaccines against burkholderia pseudomallei.

Author information

1
Department of Immunology and Infection, London School of Hygiene and Tropical Medicine London, UK.

Abstract

Burkholderia pseudomallei is a Gram-negative bacterium which is the causative agent of melioidosis, a disease which carries a high mortality and morbidity rate in endemic areas of South East Asia and Northern Australia. At present there is no available human vaccine that protects against B. pseudomallei, and with the current limitations of antibiotic treatment, the development of new preventative and therapeutic interventions is crucial. This review considers the multiple elements of melioidosis vaccine research including: (i) the immune responses required for protective immunity, (ii) animal models available for preclinical testing of potential candidates, (iii) the different experimental vaccine strategies which are being pursued, and (iv) the obstacles and opportunities for eventual registration of a licensed vaccine in humans.

KEYWORDS:

Burkholderia pseudomallei; melioidosis; vaccines

Supplemental Content

Full text links

Icon for Frontiers Media SA Icon for PubMed Central
Loading ...
Support Center